UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20369
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported: January 15, 2016
RORINE INTERNATIONAL HOLDING CORPORATION |
| (Exact name of registrant as specified in charter) |
| Nevada | | 000-53156 | | 45-0588917 |
| | | | | |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| Suite 325-7582, Las Vegas Blvd South | | 89123 |
| Las Vegas, Nevada | | |
| | | |
| (Address of principal executive offices) | | (Zip code) |
| | Issuer’s telephone number, including area code: 1-702-560-4373 | |
| | (Registrant's telephone number including area code) | |
| | | |
| | (Former Name or former address, if changed since last report) | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
On January 15, 2016, Rorine International Holding Corporation issued a press release announcing that it had entered into a marketing and distribution agreement with Rich Group concerning the marketing of Eastern alternative medical packages related to Type II Diabetes outside China to non-traditional markets where permitted by applicable law.
Item 9.01. Financial Statements and Exhibits.
99.1 Press release issued on January 15, 2016
SIGNATURES
Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| | RORINE INTERNATIONAL HOLDING CORPORATION |
| | | |
| | | /s/ Mr. Tesheb Casimir |
| | | |
| | | Mr. Tesheb Casimir, Chief Executive Officer |
| | | (Principal Executive Officer) |
| | | |
| | | /s/ Mr. Tan Sew Hock |
| | | Mr. Tan Sew Hock Chief Financial Officer |
| | | (Principal Financial Officer) |
Dated: January 18, 2016
2
